A machine learning-based framework for predicting type 2 diabetes mellitus using hematological indices.

Authors

Niloufar Kamkar, Saleh Behzadi, Vahid Mahdavizadeh, Masoome Maali Tafti, Amin Mansoori, Mohadeseh Poudineh, Habibollah Esmaily, Majid Ghayour-Mobarhan

Published in

American heart journal plus : cardiology research and practice. Volume 69. Pages 100854. Epub Aug 03, 2026.

Abstract

This study aimed to develop a machine learning (ML) framework to predict incident type 2 diabetes mellitus (T2DM) using routinely available hematological and renal biomarkers, and to assess their added predictive value over conventional clinical risk factors.
We analyzed data from 6093 diabetes-free participants from the prospective Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) cohort. Predictors included white blood cell count (WBC), red blood cell count (RBC), red cell distribution width (RDW), and other hematological/renal factors. We employed logistic regression and multiple ML models (Random Forest, XGBoost, LightGBM), optimized via grid search and cross-validation.
Multivariate logistic regression identified RBC, WBC, and RDW as independent predictors of T2DM. The Random Forest model achieved the highest performance with a ROC-AUC of 0.73, an accuracy of 0.67, and correctly identified 223 of 347 incident T2DM cases Using a probability threshold of 0.20, the Random Forest model achieved a sensitivity of 0.618, a specificity of 0.707, a positive predictive value (PPV) of 0.327, and a negative predictive value (NPV) of 0.889 on the independent test set Feature importance analysis identified metabolic syndrome, BMI, uric acid, and age as the strongest contributors, while WBC, RBC, and NLR were the most influential hematological predictors.
Routine hematological indices, including RBC, WBC, and RDW, were independently associated with incident T2DM, while metabolic syndrome, BMI, uric acid, and age contributed most strongly to overall model prediction. ML provides a complementary approach for early risk stratification, although further validation is required before clinical implementation.

PMID:
42602976
Bibliographic data and abstract were imported from PubMed on 15 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.